Physician profile
Robert H Odell
NPI 1013957026
$1,343.76
in general payments reported to CMS, 2019-2025
19 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.45 · 2020: $269 · 2021: $128 · 2022: $440 · 2023: $115 · 2024: $52.70 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $355.20 | 2022 | |
| Nutech Spine, INC. | $197.72 | 2020 | |
| Biotronik Nro, INC. | $153.10 | 2025 | Prospera |
| Stimwave Technologies Incorporated | $115.32 | 2020-2022 | |
| Spr Therapeutics, INC | $87.83 | 2023 | Sprint Pns System |
| Boston Scientific Corporation | $56.78 | 2020-2021 | |
| Averitas Pharma INC. | $53.90 | 2023-2025 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $52.70 | 2024 | |
| Nevro Corp. | $51.95 | 2019-2022 | |
| Medtronic, INC. | $36.81 | 2022-2025 | Inceptiv |
| Abbott Laboratories | $35.15 | 2020-2021 | |
| Nalu Medical, INC. | $29.35 | 2021-2025 | Nalu Neurostimulation System |
| Protega Pharmaceutials INC | $24.59 | 2025 | Roxybond |
| Fidia Pharma USA INC. | $22.20 | 2022 | |
| Vertiflex, INC. | $17.73 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $15.89 | 2019 | |
| Biodelivery Sciences International, INC. | $13.11 | 2019 | |
| Mdd US Operations, LLC | $12.85 | 2020 | |
| Allergan, INC. | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Odell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.